Key details of the duodenal-jejunal bypass in type 2 diabetes mellitus rats

被引:1
|
作者
Han, Li-Ou [1 ]
Zhou, Li-Hong [2 ]
Cheng, Su-Jun [2 ]
Song, Chun [1 ]
Song, Chun-Fang [1 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 1, Dept Gen Surg, Harbin 150001, Heilongjiang Pr, Peoples R China
[2] Harbin Med Univ, Affiliated Hosp 1, Dept Endocrinol, Harbin 150001, Heilongjiang Pr, Peoples R China
关键词
Duodenal-jejunal bypass; Type 2 diabetes mellitus; Minimally invasive surgery; Fast-track surgery; Damage control surgery; Permissive underfeeding; Goal-directed volume therapy; Y GASTRIC BYPASS; DAMAGE CONTROL; MODEL; COMPLICATIONS; MANAGEMENT; SURGERY; DISEASE; DIET;
D O I
10.3748/wjg.v17.i45.5021
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate which surgical techniques and perioperative regimens yielded the best survival rates for diabetic rats undergoing gastric bypass. METHODS: We performed Roux-en-Y gastric bypass with reserved gastric volume, a procedure in which gastrointestinal continuity was reestablished while excluding the entire duodenum and proximal jejunal loop. We observed the procedural success rate, long-term survival, and histopathological sequelae associated with a number of technical modifications. These included: use of anatomical markers to precisely identify Treitz's ligament; careful dissection along surgical planes; careful attention to the choice of regional transection sites; reconstruction using full-thickness anastomoses; use of a minimally invasive procedure with prohemostatic pretreatment and hemorrhage control; prevention of hypo-thermic damage; reduction in the length of the procedure; and accelerated surgical recovery using fast-track surgical modalities such as perioperative permissive underfeeding and goal-directed volume therapy. RESULTS: The series of modifications we adopted reduced operation time from 110.02 +/- 12.34 min to 78.39 +/- 7.26 min ( P < 0.01), and the procedural success rate increased from 43.3% (13/30) to 90% (18/20) (P < 0.01), with a long-term survival of 83.3% (15/18) (P < 0.01). CONCLUSION: Using a number of fast-track and damage control surgical techniques, we have successfully established a stable model of gastric bypass in diabetic rats. (C) 2011 Baishideng. All rights reserved.
引用
收藏
页码:5021 / 5027
页数:7
相关论文
共 50 条
  • [31] Effect of Duodenal-Jejunal Bypass Liner on Cardiovascular Risk in Patients with Type 2 Diabetes and Metabolic Syndrome
    Laubner, Katharina
    Roehlen, Natascha
    Bettinger, Dominik
    Hilger, Hanna
    Koenig, Carolin
    Krebs, Andreas
    Seufert, Jochen
    DIABETES, 2019, 68
  • [32] Effects of Duodenal-Jejunal Exclusion and New Bilio-Pancreatic Diversion on Blood Glucose in Rats with Type 2 Diabetes Mellitus
    Weng, Shan Geng
    Zhang, Bin
    Wang, Xiaojian
    Chen, Hao
    OBESITY SURGERY, 2017, 27 (08) : 2067 - 2072
  • [33] Effect of Duodenal-Jejunal Bypass Surgery on Glycemic Control in Type 2 Diabetes: A Randomized Controlled Trial
    Petry, Tarissa Z.
    Fabbrini, Elisa
    Otoch, Jose P.
    Carmona, Murilo A.
    Caravatto, Pedro P.
    Salles, Joao E.
    Sarian, Thais
    Correa, Jose L.
    Schiavon, Carlos A.
    Patterson, Bruce W.
    Cohen, Ricardo
    Klein, Samuel
    OBESITY, 2015, 23 (10) : 1973 - 1979
  • [34] A Pilot Study of the Duodenal-Jejunal Bypass Liner in Low Body Mass Index Type 2 Diabetes
    Cohen, Ricardo Vitor
    Galvao Neto, Manoel
    Correa, Jose Luis
    Sakai, Paulo
    Martins, Bruno
    Schiavon, Carlos Aurelio
    Petry, Tarissa
    Salles, Joao Eduardo
    Mamedio, Cristina
    Sorli, Christopher
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (02): : E279 - E282
  • [35] Effects of Duodenal-Jejunal Exclusion and New Bilio-Pancreatic Diversion on Blood Glucose in Rats with Type 2 Diabetes Mellitus
    Shan Geng Weng
    Bin Zhang
    Xiaojian Wang
    Hao Chen
    Obesity Surgery, 2017, 27 : 2067 - 2072
  • [36] WHAT HAPPENS TO OVERWEIGHT AND TYPE 2 DIABETES AFTER EXPLANTATION OF THE ENDOBARRIER/DUODENAL-JEJUNAL BYPASS LINER?
    Betzel, B.
    Koehestanie, P.
    Aarts, E.
    Homan, J.
    Dogan, K.
    Wahab, P.
    Groenen, M.
    Janssen, I.
    Berends, F.
    OBESITY SURGERY, 2014, 24 (08) : 1309 - 1309
  • [37] The duodenal-jejunal bypass sleeve (EndoBarrier Gastrointestinal Liner) for weight loss and treatment of type 2 diabetes
    Patel, Shaneel R. H.
    Hakim, David
    Mason, John
    Hakim, Nadey
    SURGERY FOR OBESITY AND RELATED DISEASES, 2013, 9 (03) : 482 - 484
  • [38] Pilot Clinical Study of an Endoscopic, Removable Duodenal-Jejunal Bypass Liner for the Treatment of Type 2 Diabetes
    Rodriguez, Leonardo
    Reyes, Eliana
    Fagalde, Pilar
    Oltra, Maria Soledad
    Saba, Jorge
    Aylwin, Carmen Gloria
    Prieto, Carolina
    Ramos, Almino
    Galvao, Manoel
    Gersin, Keith S.
    Sorli, Christopher
    DIABETES TECHNOLOGY & THERAPEUTICS, 2009, 11 (11) : 725 - 732
  • [39] Alterations in gut microbiota during remission and recurrence of diabetes after duodenal-jejunal bypass in rats
    Ming-Wei Zhong
    Shao-Zhuang Liu
    Guang-Yong Zhang
    Xiang Zhang
    Teng Liu
    San-Yuan Hu
    World Journal of Gastroenterology, 2016, (29) : 6706 - 6715
  • [40] Alterations in gut microbiota during remission and recurrence of diabetes after duodenal-jejunal bypass in rats
    Zhong, Ming-Wei
    Liu, Shao-Zhuang
    Zhang, Guang-Yong
    Zhang, Xiang
    Liu, Teng
    Hu, San-Yuan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (29) : 6706 - 6715